Barratt Redrow plc (BTRW)
London Exchange · UK · prices in GBX · close of 22 Oct 2026
Key indicators
| Last close | GBX 322.00 |
|---|---|
| 52-week range | 235.40 – 410.29 |
| Return, 1 month / 3 months | +4.1% / +10.2% |
| Return, 1 year / 3 years | −20.7% / −17.8% |
| Trend | Uptrend |
| RSI (14) | 59 |
| Volatility (1 year) | 36.1% |
| Worst drawdown (1 year) | -41.1% |
| Average daily value traded | 2,059.96M GBX |
| Dividend yield | 1.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Barratt Redrow plc is a British housebuilder formed from the combination of Barratt Developments and Redrow. It builds new homes for private buyers and for housing associations, ranging from apartments and starter homes to larger family houses and premium properties sold under its various brand names. The company operates across the United Kingdom, from its head offices in the English Midlands, and also provides related services such as part-exchange and shared ownership arrangements for its customers.
The shares are listed on the London Exchange in UK under the code BTRW, and the price on this page is in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Barratt Redrow plc (BTRW) trades on the London Exchange in UK. It last closed at GBX 322.00 on 22 October 2026.
Its price-based Market X-Ray is 57 out of 100 (a fair price profile), ranking 1,600 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 20.7% and over the last three months it rose 10.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 56 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 6.3% | ||
| From 52-week high | -21.3% | ||
| Momentum | 60 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 10.2% | ||
| 6-month return | 21.0% | ||
| 12-month return, skipping the last month | -23.8% | ||
| Stability (higher is calmer) | 39 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 36.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -41.1% | ||
| Liquidity | 98 · Strong | Trades actively. | |
| Average daily value traded | 2,059.96M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | 37 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.9% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | +3.9% |
|---|---|
| 1 month | +4.1% |
| 3 months | +10.2% |
| 6 months | +21.0% |
| 1 year | −20.7% |
| 3 years | −17.8% |
| 5 years | −49.8% |
Signals
| 50-day / 200-day average | 309.28 / 302.89 |
|---|---|
| Golden / death cross (60 days) | Golden, 16 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 10.17 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 8 Oct 2026 | GBP 0.0100 |
| 2 Apr 2026 | GBP 0.0500 |
| 9 Oct 2025 | GBP 0.1210 |
| 3 Apr 2025 | GBP 0.0550 |
| 26 Sep 2024 | GBP 0.1180 |
| 11 Apr 2024 | GBP 0.0440 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.